TY - GEN AU - Das,Diganta B. AU - Arthanareeswaran,G AU - Mabrouk,Mostafa AU - Beherei,Hanan H. AU - Das,Diganta B. AU - Arthanareeswaran,G AU - Mabrouk,Mostafa AU - Beherei,Hanan H. TI - Pharmaceutical Particulates and Membranes for Delivery of Drugs and Bioactive Molecules SN - books978-3-03936-393-3 PY - 2020/// CY - Basel, Switzerland PB - MDPI - Multidisciplinary Digital Publishing Institute KW - Research & information: general KW - bicssc KW - Biology, life sciences KW - alginate gelispheres KW - textural analysis KW - crosslinked matrices KW - PLGA discs KW - prolonged release KW - powder flow properties KW - microfluidics KW - coculture KW - HER2 KW - polystyrene µPs KW - biofunctionalization KW - coaxial electrospraying KW - polymeric nanoparticles KW - spreading angle KW - process-property-performance relationship KW - nanoemulsion KW - mixture design KW - aqueous humor KW - antimicrobial activity KW - sustained release pellets KW - double coating layer KW - loxoprofen KW - citric acid KW - pharmacokinetic studies KW - biomimetic magnetite KW - drug delivery KW - magnetic hyperthermia KW - magnetite KW - MamC KW - nanoparticles stability KW - pharmaceutical particulates KW - membranes KW - drug delivery systems KW - bio-imaging KW - bioactive molecules KW - composite KW - N-hydroxyphthalimide KW - carbon dots KW - polymer gels KW - antitumoral activity KW - wound dressing KW - polymeric membrane KW - nanoparticles KW - curcumin KW - alginate KW - pluronic F68 KW - drug skin permeation KW - Franz cells KW - tape stripping KW - wound infection KW - biofilm KW - pseudomonas aeruginosa KW - antimicrobial delivery KW - polyvinylpyrrolidone KW - nanofibers KW - red blood cells membrane KW - arsenic trioxide KW - sodium alginate nanoparticles KW - reduce toxicity KW - anti-tumor KW - pediatric drug delivery KW - tuberculosis KW - reconstitutable dry suspension KW - isoniazid KW - polymer-lipid KW - microparticulate KW - direct emulsification KW - n/a N1 - Open Access N2 - This book is a collection of papers published in the Special Issue of Pharmaceutics, entitled "Pharmaceutical Particulates and Membranes for Delivery of Drugs and Bioactive Molecules". A drug release profile is a consequential factor for nanoparticle application, directly related to drug stability and therapeutic results, as well as formulation development. Pharmaceutical particulates of different sizes and shapes (e.g., liposomes, oil-in-water emulsions, polymeric nano- and microspheres, metallic nanoparticles (NPs) such as gold, silver and iron oxide crystals, and core-shell hybrid NPs) offer many diagnostic and therapeutic applications. Membranes are also extensively utilized in many applications. They are especially beneficial to the distribution of macromolecular drugs and biopharmaceutical drugs (peptides, proteins, antibodies, oligonucleotides, plasmids, and viruses) with physicochemical and pharmacokinetic vulnerability. The delivery of drugs and bioactive molecules using particulates and membranes has gained a great deal of attention for various applications, such as the treatment of secondary infections, cancer treatment, skin regeneration, orthopaedic applications, and antimicrobial drug delivery. In addition, several production techniques have been utilized for the fabrication of particulates and membranes in the last decade, which include lyophilisation, micro-emulsion, nano-spray dryer, nano-electrospinning, slip casting and 3D printers. Therefore, pharmaceutical particulates and membranes possess excellent prospects to deliver drugs and bioactive molecules with the potential to improve new delivery strategies like sustained and controlled release UR - https://mdpi.com/books/pdfview/book/2420 UR - https://directory.doabooks.org/handle/20.500.12854/68657 ER -